CR
Corbion N.V.
CRBN.AS · AMS
22.32 € +1.36% (+0.30 €)
1M -1.68%
Market Cap 1.29B €
P/E Ratio 17.20x
Div. Yield 4.48%
ROE 9.98%
Bulios Fair Price
12.47 €
44.1% downside
Current Price
22.32 €
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CRBN.AS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
8/9Valuation
71 /100
Cheap P/E 17.20x
EV/EBITDA 8.52x
P/S 1.01x
Growth
27 /100
Declining EPS growth 5.11%
Rev. growth 4.56%
Book val. growth 5.88%
Profitability
68 /100
Strong Gross margin 26.06%
Net margin 5.90%
Op. margin 9.19%
Quality
67 /100
Excellent ROIC 7.59%
ROE 9.98%
ROA 5.28%
Debt
80 /100
Low Debt/Equity 0.65x
Current ratio 1.89x
Int. coverage 5.27x
Stability
72 /100
Stable Beta 0.94x
Rev. volatility 5.49%
EPS volatility 120.27%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CRBN.AS
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Olivier Rigaud
Employees
2,363
Headquarters
Amsterdam
Upcoming events
26 FEB
Earnings
Upcoming earnings report